Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms

Annals of Surgery

Volumn 239, Issue 6, 2004, Pages 849-858

  Reavis, Kevin M ^a   Morris, Cynthia D ^b   Gopal, Deepak V ^c   Hunter, John G ^a   Jobe, Blair A ^a   Schirmer, Bruce D ^d   McFadden, David W ^d   Martin, Robert ^d   Eubanks, Steve ^d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Surgical Service P3GS ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER SCREENING; CASE CONTROL STUDY; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DYSPHAGIA; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HOARSENESS; HUMAN; LARYNX; MAJOR CLINICAL STUDY; MALE; PHARYNX; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINUSITIS; SORE THROAT; SYMPTOMATOLOGY;

EID: 2442657941     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000128303.05898.ee     Document Type: Conference Paper

References (36)

1. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol. 1999;26(5 suppl 15):2-8.
2. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control. 1996;7:322-327.
3. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26-33.
4. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesopageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
5. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus: does it help? J Thorac Cardiovasc Surg. 1993;105:383-387;discussion 387-388.
6. van Sandick JW, van Lanschot JJ, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998;43:216-222.
7. Peters JH, Clark GW, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108:813-821;discussion 821-822.
8. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 years cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. Br Med J. 2000;321:1252-1255.
9. Gopal DV, Jobe BA. Screening for Barrett's esophagus may not reduce morbidity and mortality due to esophageal adenocarcinoma [Commentary]. Evidence Based Oncol. 2002;3:144-145.
10. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461-467.
11. Jaspersen D, Diehl KL, Geyer P, et al. Diagnostic omeprazole test in suspected reflux-associated chronic cough. Pneumologie. 1999;53:438-441.
12. Theodoropoulos DS, Ledford DK, Lockey RF, et al. Prevalence of upper respiratory symptoms in patients with symptomatic gastroesophageal reflux disease. Am J Respir Crit Care Med. 2001;164:72-76.
13. Ulualp SO, Toohill RJ, Hoffmann R, et al. Pharyngeal pH monitoring in patients with posterior laryngitis. Otolaryngol Head Neck Surg. 1999;120:672-677.
14. Ulualp SO, Toohill RJ, Hoffmann R, et al. Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol. 1999;13:197-202.
15. Ulualp SO, Toohill RJ, Shaker R. Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders. Otolaryngol Head Neck Surg. 1999;121:725-730.
16. Ulualp SO, Toohill RJ, Shaker R. Outcomes of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg. 2001;124:16-22.
17. Toohill RJ, Ulualp SO, Shaker R. Evaluation of gastroesophageal reflux in patients with laryngotracheal stenosis. Ann Otol Rhinol Laryngol. 1998;107:1010-1014.
18. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology. 1995;109:1575-1582.
19. Kuhn J, Toohill RJ, Ulualp SO, et al. Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope. 1998;108(8 Pt 1):1146-1149.
20. el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113:755-760.
21. Eubanks TR, Omelanczuk PE, Maronian N, et al. Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg. 2001;5:183-190;discussion 190-191.
22. Avidan B, Sonnenberg A, Schnell TG, et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002;97:1930-1936.
23. Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. Br J Cancer. 2001;85:1317-1321.
24. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus: the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:1028-1032.
25. Lieberman D, Oehkle M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol. 1997;92:1293-1297.
26. Johnson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol. 1987;9:23-27.
27. Loffeld RJ. Young patients with Barrett's oesophagus experience less reflux complaints. Digestion. 2001;64:151-154.
28. Falk GW. Screening and surveillance of Barrett's esophagus. In: Sampliner R, Sharma P, eds. Barrett's Esophagus and Esophageal Adenocarcinoma. MA: Blackwell Science, 2001.
29. Sato T, Miwa K, Sahara H, et al. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res. 2002;22:39-44.
30. Avidan B, Sonnenberg A, Schnell TG, et al. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci. 2002;47:256-264.
31. Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537-1541.
32. Hameeteman W, Tytgat GN, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249-1256.
33. Ulualp SO, Toohill R, Kern MY, et al. Pharyngo-UES contractile reflex in patients with posterior laryngitis. Laryngoscope. 1998;108:1354-1357.
34. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999;94:2037-2042.
35. Cheng KK, Sharp L, McKinney PA, et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer. 2000;83:127-132.
36. Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.